Tuberculosis updates;Actualités de la tuberculose

Revue des Maladies Respiratoires

Volumn 23, Issue 5 C2, 2006, Pages

  Chouaid, C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; MOXIFLOXACIN; RIFAPENTINE;

ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST;

EID: 33845335830     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(06)72006-x     Document Type: Article

References (27)

1. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M : Tuberculosis and homelessness in the United States, 1994-2003. JAMA 2005 ; 293 : 2762-6.
2. Richeldi L : An Update on the Diagnosis of Tuberculosis Infection. Am J Respir Crit Care Med 2006 Jun 23 ; Epub ahead of print.
3. Bouvet E, Abiteboul D, Antoun F, Bessa Z, Billy C, Dautzenberg B : Prévention et prise en charge de la tuberculose en France (synthèse et recommandations du groupe de travail du Conseil Supérieur d'Hygiène Publique de France 2002-2003). Rev Mal Respir 2003 ; 20 : 6.
4. Jansens J.P., Roux-Lombard P, Perneger T, et coll. : Comparison of a T-cell based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection s(LTBI) in contact-tracing procedures. Eur Respir J 2005 ; 26 : S241.
5. Pathan A, A. Wilkinson K, Klenerman P et coll. : Direct ex vivo analysis of antigen-pecific IFN-γ-Secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: association with clinical disease state and effect of treatment. J Immunol 2001 ; 167 : 5217-25.
6. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et coll. : Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004 ; 170 : 59-64.
7. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P : Latent Tuberculosis in HIV positive, diagnosed by the M. tuberculosis Specific Interferon Gamma test. Respir Res 2006 ; 7 : 56-9.
8. Ferrara G, Losi M, Pezzi AM, Meacci M, Cagarelli R, Marchetti I, et coll. : Tuberculosis-Specific T Cell interferon-gamma réponse among elderly recent contacts with high prevalence of pre-existing latent tuberculosis infection. Proc Am Thorac Soc 2006 ; 3 : A475.
9. Mazurek GH, Jereb J, LoBue P, Iademarco MF, Metchock B, Vernon A : Guidelines for using the Quantiferon®-TB gold test for detecting Mycobacterium tuberculosis infection, united states. MMWR2005/54(RR15) ; 49-55.
10. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et coll. : Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006 ; 367 : 1328-34.
11. Russo C, Lancella L, Krzysztofiak A, Menichella D : Quantiferon GOLD for the diagnosis of paediatric TB in Italy. Proc Am Thorac Soc 2006 ; 3 : A475.
12. Bossink AWJ, Arend SM, Leyten EMS, Koster J, Bouwman JJM, Thijsen SFT : Comparison between two gamma-interferon based blood tests and the tuberculin skin test for detection of recent latent tuberculosis infection during mass contact tracing. Proc Am Thorac Soc 2006 ; 3 : A475.
13. Mazurek GH, Zajdowicz, MJ, Toney SR, Costigan DJ, Daniels LJ, LoBue P, Keep LW : Detection of Mycobacterium tuberculosis infection in United States navy recruits using tuberculin skin tests and whole blood interferon-gamma release assays. Proc Am Thorac Soc 2006 ; 3 : A475.
14. Haley CA, Thompson JL, Holt EL, Garman KN, GHES K, Yu C, Bowker TV : Treatment of adults with latent tuberculosis infection in tennessee's statewide targeted testing program. Proc Am Thorac Soc 2006 ; 3 : A746.
15. Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR : The scope and impact of treatment of latent tuberculosis infection in the united states and Canada. Proc Am Thorac Soc 2006 ; 3 : A745.
16. Wada NI, Schluger NW : Efficacy of large-scale treatment of latent tuberculosis infection: Results from a mathematical model. Proc Am Thorac Soc 2006 ; 3 : A745.
17. Grosset JH, Nuermberger EL, Rosenthal I, Tyagi S, Williams K, Bishai WR : A PA-824 (Pa)-containing regimen without Rifampin® and isoniazid (H) is as active as first-line regimens in the murine model of tuberculosis (TB). Proc Am Thorac Soc 2006 ; 3 : A744.
18. Nuermberger EL, Williams K, Tyagi S, Rosenthal I, Bishai W, Grosset J : Evaluation of the investigational new drug PA-824 and its potential role in the first-line treatment of tuberculosis using the mouse model. Proc Am Thorac Soc 2006 ; 3 : A744.
19. Rosenthal IM, Nuermberger EL, Williams K, BS, Vernon A, Bishai W, Grosset JH : Twice-Weekly Rifapentine (P)-containing regimens produce stable cure after 4 months in murine TB. Proc Am Thorac Soc 2006 ; 3 : A744.
20. Weiner M, Burman W, Luo CC, Peloquin C, Engle M, Goldberg S, et coll. : Tuberculosis trials consortium, Denver, CO, Atlanta, GA, San Antonio, TX The effects of Rifampin and muman multidrug resistance gene polymorphism on serum concentrations of moxifloxacin. Proc Am Thorac Soc 2006 ; 3 : A745.
21. Kim YH, Seo KH, Na JO, Uh ST, Park CS : Retrial of identical agents in patients with toxic hepatitis caused by first line antituberculosis drugs. Proc Am Thorac Soc 2006 ; 3 : A745.
22. Gershon AS, Wobeser W, Tu JV : Age-Related rates of INH-Induced hepatotoxicity adjusted for completion of treatment - A meta-analysis. Proc Am Thorac Soc 2006 ; 3 : A744.
23. Park IN, Lee JY, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS : Effectiveness and adverse reactions of half-daily dose linezolid in patients with intractable pulmonary MDR tuberculosis. Proc Am Thorac Soc 2006 ; 3 : A394.
24. Kim DY, Cho JS, Park JH, Oh SH, Park SK, Kim H, et coll. : Comparison of the outcome of chemotherapy for multidrug-resistant tuberculosis according to the regimens based on previous history of using any second-line drugs or drug susceptibility testing. Proc Am Thorac Soc 2006 ; 3 : A395.
25. Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, et coll. : Moxifloxacin versus ethambutol in the first two months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006 ; May 4 : Epub ahead of print.
26. Rosenthal IM, Williams K, Tyagi S, Peloquin CA, Vernon AA, Bishai WR, et coll. : Potent twice-weekly rifapentine-containing regimens in murine tuberculosis. Am J Respir Crit Care Med 2006 ; 174 : 94-101.
27. Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, et coll. : A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005 ; 307 : 223-7.